ArticleTranslational psychiatry2026
Oxytocin attenuates isolation-evoked emotional and social behavioral dysregulation through neural, immune, and microbiota mechanisms.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic social isolation (SI) beginning in adolescence can lead to serious mental health problems and social skill deficits, potentially linked to altered development and function of the prefrontal cortex (PFC), a brain region frequently implicated in neuropsychiatric disorders. Oxytocin (OXT), a neuropeptide renowned for its prosocial effects, holds significant potential as an intervention for neuropsychiatric disorders. However, the efficacy of OXT in ameliorating mental disorders induced by adolescent-onset chronic SI remains uncertain. In this work, four-week-old C57BL/6 J mice were subjected to three months of SI, and subsequent alterations in their emotional and social behaviors were assessed. Thereafter, OXT was administered intranasally to SI mice to evaluate the effects of the intervention. The results show that exposure to SI leads to anxiety- and depression-like behaviors, deficits in social novelty recognition, and long-term impairments in social memory. OXT intervention effectively reversed the damage caused by SI, including improvements in behavioral deficits, increased expression of MAP-2 and PSD-95 in PFC, downregulation of abnormally elevated OXT receptor levels, reduction of neuroinflammation, and modulation of gut microbiota homeostasis. Our study confirms the therapeutic effects of OXT in reversing isolation-induced neuropsychiatric disorders and elucidates its potential regulatory mechanisms, offering important implications for clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.